Association of the Kinesin Motor KIF1A with the Multimodular Protein Liprin-α by Shin, Hyewon et al.
Association of the Kinesin Motor KIF1A with the Multimodular
Protein Liprin-*
Received for publication, November 21, 2002
Published, JBC Papers in Press, January 8, 2003, DOI 10.1074/jbc.M211874200
Hyewon Shin‡, Michael Wyszynski§¶, Kyung-Hye Huh‡, Juli G. Valtschanoff, Jae-Ran Lee‡,
Jaewon Ko‡, Michel Streuli**‡‡, Richard J. Weinberg, Morgan Sheng§ §§, and Eunjoon Kim‡¶¶
From the ‡Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701,
Korea, the §Center for Learning and Memory, RIKEN-MIT Neuroscience Research Center and Howard Hughes Medical
Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, the Department of Cell Biology and
Anatomy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, and the **Department of
Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School,
Boston, Massachusetts 02115
Liprin-/SYD-2 is a multimodular scaffolding protein
important for presynaptic differentiation and postsyn-
aptic targeting of -amino-3-hydroxy-5-methyl-4-isox-
azoleproprionic acid glutamate receptors. However, the
molecular mechanisms underlying these functions re-
main largely unknown. Here we report that liprin- in-
teracts with the neuron-specific kinesin motor KIF1A.
KIF1A colocalizes with liprin- in various subcellular
regions of neurons. KIF1A coaccumulates with liprin-
in ligated sciatic nerves. KIF1A cofractionates and
coimmunopreciptates with liprin- and various liprin-
-associated membrane, signaling, and scaffolding
proteins including -amino-3-hydroxy-5-methyl-4-isox-
azoleproprionic acid receptors, GRIP/ABP, RIM, GIT1,
and PIX. These results suggest that liprin- functions
as a KIF1A receptor, linking KIF1A to various liprin--
associated proteins for their transport in neurons.
The liprin-/SYD-2 family of proteins was originally identi-
fied as a cytosolic binding partner of the LAR family of receptor
protein-tyrosine phosphatases (1). Liprin- contains various
domains for protein interactions including a long coiled coil
region in the N-terminal half, three SAM domains in the mid-
dle, and a PDZ-binding motif at the C terminus. The N-termi-
nal coiled-coil region of liprin- mediates homomultimerization
(1) and interacts with GIT/Cat/p95-APP/PKL (2), a family of
multidomain proteins with GTPase-activating protein activity
for ADP-ribosylation factor small GTP-binding proteins (3–7),
as well as RIM1 (Rab3-interacting molecule) (8), a scaffolding
protein at the presynaptic active zone regulating neurotrans-
mitter release (8, 9). The SAM domains of liprin- interact with
the intracellular domain of LAR (1). The C terminus of liprin-
interacts with the GRIP/ABP family of multi-PDZ proteins,
which are known to bind various membrane, cell adhesion, and
signaling proteins including AMPA1 glutamate receptors
(GluRs) (10–14), ephrin ligands, and receptors (15–17) and
GRASP-1, a neuronal Ras-specific guanine nucleotide ex-
change factor (18). These results suggest that liprin- may
function as a multimodular scaffolding protein.
Functionally, genetic deletion of syd-2 (for synaptic defective-
2), a Caenorhabditis elegans homolog of mammalian liprin-,
results in a diffuse distribution of presynaptic markers, length-
ening of the presynaptic active zone, and impairment of syn-
aptic transmission (19). Similarly, genetic deletion of Dliprin-,
a Drosophila homolog of liprin-, leads to an alteration of the
size and shape of active zones (20). In addition, disruption of
the interaction between liprin- and GRIP eliminates surface
clustering of AMPA receptors in dendrites of neurons (21).
These results suggest that liprin-/SYD-2 regulates presynap-
tic differentiation of active zone as well as postsynaptic target-
ing of AMPA receptors. However, it remains largely unknown
how liprin- regulates presynaptic differentiation and postsyn-
aptic receptor targeting. Importantly, liprin- distributes to
various nonsynaptic structures in axons and dendrites (21),
suggesting that liprin- may have novel functions at extrasyn-
aptic sites in addition to its suggested role as an organizer of
synaptic multiprotein complexes.
The kinesin superfamily (KIF) of motor proteins transports
cargo vesicles or organelles on microtubule tracks (22, 23).
KIF1A, a member of the KIF1/Unc104 family of proteins (24), is
a neuron-specific kinesin motor known to transport synaptic
vesicle precursors containing synaptophysin, synaptotagmin,
and Rab3A (24, 25). In support of this, genetic deletion of
unc-104, a C. elegans homolog of KIF1A (26), results in the
accumulation of clear vesicles in the cell body (27). Mutation in
the KIF1A gene in mice leads to a similar accumulation of
vesicles in the cell body and neuronal death (28). Recently, fast
and processive movements of Unc104/KIF1A were observed in
living C. elegans and mammalian neurons (29, 30), and molec-
ular mechanisms underlying the processive movement of
Unc104/KIF1A have been extensively characterized (31–34).
However, relatively little is known about whether KIF1A
transports cargoes other than synaptic vesicle precursors and
about the manner in which KIF1A interacts with specific
cargoes.
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We report here a direct interaction between KIF1A and
liprin-, which links KIF1A to various liprin--associated pro-
teins including AMPA receptors, GRIP, RIM, GIT1, and PIX.
Our results suggest that liprin- functions as a KIF1A “recep-
tor” linking the KIF1A motor to a cargo of liprin--associated
proteins.
EXPERIMENTAL PROCEDURES
Yeast Two-hybrid Screen and Assay—Liprin-1 (aa 351–1105) and
liprin-4 (aa 1–863) were amplified by PCR and subcloned to pBHA
bait vector (LexA DNA binding domain). The following deletions of
KIF1A were amplified by PCR and subcloned in frame into the pGAD10
prey vector (GAL4 activation domain; Clontech): 501–800, 501–937,
501–1105, 657–1105, 717–937, 717–1105, and 923–1105. Deletions of
liprin-1 were subcloned into pGAD10 vector: aa 1–221, 1–673, 1–848,
217–553, 221–673, 351–553, 351–673, 513–673, and 668–1202.
KIF1B (aa 666–1150) and KIF1B (aa 697–1223) were amplified by
reverse transcription-PCR and subcloned into pGAD10. All yeast two-
hybrid constructs were confirmed by DNA sequencing.
Coimmunoprecipitation in Heterologous Cells—For the KIF1A ex-
pression construct, the full-length KIF1A cDNA was amplified by re-
verse transcription-PCR, digested with HindIII and EcoRI, and sub-
cloned into GW1 (British Biotechnology). HEK293T cells transfected
with GW1-KIF1A and pMT2-HA-liprin-1 were extracted with Tris-
buffered saline containing 1% Triton X-100 and incubated with HA
antibodies (mouse monoclonal; 4 g/ml) or mouse IgG (4 g/ml), fol-
lowed by incubation with protein A-Sepharose (Amersham Biosciences).
Immunoprecipitates were immunoblotted with HA (rabbit polyclonal; 1
g/ml) and KIF1A (1131; 1 g/ml) antibodies.
Antibodies—To generate fusion protein immunogens, regions of
KIF1A (aa 657–937 for 1131 antibodies) and liprin-1 (aa 351–673 for
1120 and 818–1202 for 1127 antibodies) were amplified by PCR and
subcloned into pRSETB (vector for H6 fusion protein; Invitrogen). Fu-
sion proteins were purified using Probond resin (Invitrogen). Affinity
purification of specific antibodies was performed using immunogen
immobilized on polyvinylidene difluoride membrane (Amersham Bio-
sciences). The specificity of KIF1A (1131) antibodies was determined by
Western blot analysis on GST-KIF1A (aa 657–937) and GST-KIF1B
(aa 697–1223). To examine the reactivity of liprin- antibodies (1120
and 1127) against the liprin- family members, COS cell lysates trans-
fected with HA-liprin-1 or HA-liprin-2 were immunoblotted with
liprin- (1120, 1127) and HA (mouse monoclonal; Roche Molecular
Biochemicals) antibodies. Other antibodies used include GRIP (C8399;
pan-GRIP antibody) (10, 11), GST (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA), GluR1 (Chemicon), PSD-95 (K23/58; Upstate Biotech-
nology, Inc., Lake Placid, NY), GluR2/3 (Chemicon), synaptotagmin
(Sigma), syntaxin (Sigma), MAP2 (Sigma), neurofilament-H (neurofila-
ment 200; Sigma), cortactin (Upstate Biotechnology), mouse mono-
clonal HA (Roche Molecular Biochemicals), rabbit polyclonal HA (Santa
Cruz Biotechnology), GIT1 (2), and RIM (Transduction Laboratories)
antibodies.
Immunohistochemistry and Immunoelectron Microscopy—For immu-
nofluorescence staining of rat brain sections, adult rats were perfused
with 4% paraformaldehyde, and brain sections were cut using a vi-
bratome. Brain sections were permeabilized with phosphate-buffered
saline containing 50% ethanol at room temperature for 30 min, incu-
bated overnight with combinations of KIF1A (1131; 3 g/ml), liprin-
(1127; 3 g/ml), MAP2 (1:200), neurofilament-H (1:100), and GRIP
(C8399; 3 g/ml) antibodies, followed by incubation with Cy3-, fluores-
cein isothiocyanate-, or Cy5-conjugated secondary antibodies at
dilutions of 1:1000, 1:300, and 1:500, respectively (Jackson Immunore-
search). Images were captured using an LSM510 confocal laser-scan-
ning microscope (Zeiss). Postembedding immunogold electron micros-
copy with KIF1A (1131; 3 g/ml) antibodies was performed and
quantified as described previously (35).
Subcellular Fractionation—Subcellular fractions of whole rat brain
were prepared as previously described (11). In brief, rat brain homoge-
nates (H in Fig. 6) were centrifuged at 900  g to remove nuclei and
other large debris (P1). The supernatant was centrifuged at 12,000  g
to obtain a crude synaptosomal fraction (P2). The supernatant (S2) was
centrifuged at 250,000  g to obtain light membranes (P3) and cytosolic
fraction (S3). In parallel, the P2 fraction was subjected to hypotonic
lysis and centrifuged at 25,000  g to precipitate synaptosomal mem-
branes (LP1). The supernatant (LS1) was further centrifuged at
250,000  g to obtain a crude synaptic vesicle-enriched fraction (LP2)
and soluble fraction (LS2). For immunoblotting, nitrocellulose or poly-
vinylidene difluoride membranes were incubated with antibodies
against KIF1A (1131; 1 g/ml), liprin- (1120; 1 g/ml), GRIP (C8399;
1 g/ml), GluR1 (1 g/ml), PSD-95 (1:1000), and synaptotagmin (1:500).
Flotation Assay and Coimmunoprecipitation—For the flotation as-
say, brains of 6-week-old rats were homogenized in homogenization
buffer (20 mM HEPES, 100 mM potassium acetate, 40 mM KCl, 5 mM
MgCl2, 320 mM sucrose, pH 7.4) supplemented with proteinase inhibi-
tors and 5 mM EGTA. Homogenate was centrifuged at 900  g for 10
min, and the supernatant was centrifuged at 12,000  g to obtain crude
synaptosomes. Crude synaptosomes were suspended in the homogeni-
zation buffer and hypotonically lysed by adding nine volumes of H2O to
release synaptic vesicles. After centrifugation at 200,000  g for 1 h, the
membrane pellet was then adjusted to 2 M sucrose and loaded onto the
bottom of a discontinuous sucrose gradient of 1.6, 1.0, and 0.3 M sucrose.
The sucrose gradient was centrifuged at 350,000  g for 3 h. Fractions
were taken from the top of the gradient to the bottom. For coimmuno-
precipitation, deoxycholate lysates (10) of the top three fractions were
incubated with antibodies against KIF1A (1131; 3 g/ml), liprin-
(1127; 3 g/ml), GluR2/3 (Chemicon; 3 g/ml), or control IgG (rabbit or
guinea pig; 3 g/ml) followed by precipitation with protein A-Sepharose
(Amersham Biosciences). Immunoprecipitates were analyzed by immu-
noblotting with KIF1A (1131; 1 g/ml), liprin- (1120; 1 g/ml), GRIP
(C8399; 1 g/ml), GluR2/3 (1 g/ml), synaptotagmin (1 g/ml), RIM (1
g/ml), GIT1 (1 g/ml), PIX (1 g/ml), syntaxin (1:400), and cortactin
(1:1000) antibodies.
Nerve Ligation Assay—Sciatic nerves of anesthetized adult rats were
ligated for 60 min followed by perfusion with 4% paraformaldehyde.
After a brief postfixation for 30 min, sections (20 m) of sciatic nerves
were cut using a cryotome and incubated overnight with primary anti-
bodies at 4 °C, followed by room temperature incubation with Cy3- or
fluorescein isothiocyanate-conjugated secondary antibodies for 3 h. Pri-
mary antibodies used include KIF1A (1131; 3 g/ml), liprin- (1127; 3
g/ml), and syntaxin (1:200). Immunofluorescence images were cap-
tured using an LSM510 confocal laser-scanning microscope (Zeiss).
Neuron Culture and Immunostaining—Low density hippocampal
primary cultures were prepared from E18 rat embryos as described
previously (36). Neurons were maintained in the neurobasal medium
supplemented with B27 (Invitrogen). For immunofluorescence staining,
neurons were fixed and permeabilized with cold methanol (70 °C) and
incubated with KIF1A (1131; 3 g/ml) and MAP2 (1:200) antibodies,
followed by incubation with Cy3- or fluorescein isothiocyanate-conju-
gated secondary antibodies.
RESULTS
Characterization of the Interaction between KIF1A and Lip-
rin- by the Yeast Two-hybrid Assay and Coimmunoprecipita-
tion—To better understand the functions of liprin-, we per-
formed a yeast two-hybrid screen of rat brain cDNA using
liprin-4, a member of the liprin- family, as bait. Out of 1 
106 yeast colonies, a cDNA fragment of KIF1A (aa 455–1105)
containing roughly the middle third of the protein was isolated.
The minimal regions required for the interaction were deter-
mined by characterizing deletion variants of KIF1A and liprin-
1, a member of the liprin- family for which a full-length
cDNA was available. The minimal liprin-1-binding region in
KIF1A was narrowed down to aa 657–1105, which we termed
the liprin--binding domain (LBD) (Fig. 1A). The minimal
KIF1A-binding region in liprin-1 was localized to a region (aa
351–673) largely within the N-terminal coiled-coil region (aa
1–650; Fig. 1B).
We then tested the specificity of interactions between mem-
bers of the KIF1 and liprin- families. In addition to liprin-4,
liprin-1 (aa 351–1202, a region corresponding to the liprin-4
bait) also interacted with the KIF1A deletions that showed
positive interaction with liprin-4 (Fig. 1A). In contrast, lip-
rin-1 and liprin-4 did not interact with KIF1B (both KIF1B
and KIF1B splice variants), another member of the KIF1
family (37–40) (Fig. 1C).
To test whether full-length KIF1A and liprin- interact in a
mammalian cell environment, we performed coimmunoprecipi-
tation experiments using HEK293T cells doubly transfected
with KIF1A and HA-tagged liprin-1 (HA-liprin-1) (Fig. 1D).
Immunoprecipitation with HA antibodies, but not control
mouse IgG, immunoprecipitated HA-liprin-1 and coprecipi-
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tated KIF1A. HA antibodies did not bring down KIF1A in the
absence of HA-liprin-1.
KIF1A and Liprin- Distribute to Both Dendrites and Axons
in Brain and Cultured Neurons—To characterize the distribu-
tion of KIF1A and liprin- in vivo, we generated specific anti-
bodies against fusion proteins of KIF1A (aa 657–937; termed
1131 antibodies) and liprin-1 (aa 351–673 for 1120 antibodies;
aa 818–1202 for 1127 antibodies) (Fig. 1, A and B). KIF1A
(1131) antibodies specifically recognized KIF1A but not
KIF1B in immunoblot analysis (Fig. 2A). The two liprin-
(1120 and 1127) antibodies reacted equally with HA-liprin-1
and HA-liprin-2 (Fig. 2B). Liprin-3 and liprin-4 were not
tested because full-length cDNAs of these isoforms were not
available. However, since members of the liprin- family share
similar aa sequences in the regions where the antibodies were
raised, it is likely that the liprin- antibodies recognize all
liprin- isoforms. When tested against rat brain samples, the
KIF1A and liprin- antibodies recognized single bands with
molecular masses of 200 and 160 kDa, respectively, which
are comparable with those of the same proteins transiently
expressed in heterologous cells (Fig. 2, C and D).
Since the yeast two-hybrid results indicated that KIF1A
interacts with liprin-, a protein that localizes to both den-
drites and axons (21), we first determined the subcellular dis-
tribution of KIF1A proteins in rat brain and cultured neurons
by immunofluorescence staining (Fig. 2, E–H and M). Interest-
ingly, we detected KIF1A in both dendrites and axons. KIF1A
overlapped with MAP2, a dendritic marker, in cortex (Fig. 2E)
and hippocampus (Fig. 2F). Consistent with its known axonal
localization (25), KIF1A also colocalized with neurofilament H
(NF-H), an axonal marker, in the white matter region of cere-
bellum (Fig. 2G) and in axon bundles of spinal cord (Fig. 2H). In
FIG. 1. Characterization of the interaction between KIF1A and liprin- by the yeast two-hybrid assay and coimmunoprecipita-
tion. A, minimal liprin--binding region in KIF1A. Deletions of KIF1A were tested for binding to liprin-1 and liprin-4 in the yeast two-hybrid
assay. The minimal liprin--binding region in KIF1A (aa 657–1105) is indicated by the thicker line. The region that the KIF1A (1131) antibodies
were raised against is indicated by a dotted line underneath the schematic of the domain organization of KIF1A. Motor, motor domain; LBD,
liprin--binding domain; PH, pleckstrin homology domain. HIS3 activity was as follows:  (60%),  (30–60%),  (10–30%),  (no
significant growth). -Galactosidase activity was as follows:  (45 min),  (45–90 min),  (90–240 min),  (no significant -galactosidase
activity). B, minimal KIF1A-binding region in liprin-1. Deletions of liprin-1 were tested for binding to KIF1A in the yeast two-hybrid assay. The
minimal KIF1A-binding region in liprin-1 (aa 351–673) is indicated by the thicker line. The regions that 1120 and 1127 liprin- antibodies were
raised against are indicated. CC, coiled-coil domain; SAM, sterile  motif. A PDZ domain-binding motif at the C terminus of liprin-1 is indicated
by a vertical black line. C, specificity of the interactions between members of the KIF1 and liprin- families. Both liprin-1 and liprin-4 interact
with KIF1A, whereas only KIF1A (not KIF1B or KIF1B) interacts with liprin-. 1–863 in liprin-4 (full aa sequence is not available) is a region
used as bait in the two-hybrid screen and corresponds to aa 351–1202 in liprin-1. D, coimmunoprecipitation between KIF1A and liprin- in
HEK293T cells. HEK293T cell lysates doubly transfected with KIF1A and HA-tagged liprin-1 (HA-liprin-1) or singly transfected with KIF1A
were immunoprecipitated with mouse monoclonal HA antibodies and immunoblotted with rabbit polyclonal HA and KIF1A (1131) antibodies.
KIF1A is specifically coimmunoprecipitated by HA antibodies (lane 2) but not by control mouse IgG (lane 3). Singly transfected KIF1A does not
cross-react with HA antibodies (lane 5). Input, 5%.
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cultured neurons, KIF1A was found in MAP2-positive den-
drites as well as MAP2-negative axons (Fig. 2M). Preincuba-
tion of KIF1A antibodies with immunogen eliminated the
KIF1A staining (Fig. 2K, an example from the CA1 region of
hippocampus). Similar to endogenous KIF1A, exogenous
KIF1A was localized to both dendrites and axons of cultured
hippocampal neurons (data not shown). Consistently, KIF1A
immunogold particles distributed to both the pre- and postsyn-
aptic sides in electron microscopic (EM) analysis (Fig. 4; details
described below). Taken together, these results suggest that
KIF1A plays a role in both dendritic and axonal transport in
neurons.
Similar to KIF1A, liprin- (1127 antibody) distributed to
both dendrites and axons as evidenced by colocalization with
MAP2 (Fig. 2I, the CA1 region of hippocampus) and NF-H (Fig.
2J, the white matter of cerebellum). The other liprin- (1120)
antibodies showed essentially the same distribution pattern
(data not shown). Liprin- staining was eliminated by prein-
cubation of the antibodies with immunogens (Fig. 2L, the CA1
region of hippocampus). In cultured hippocampal neurons, both
endogenous (21) and exogenous (data not shown) liprin- dis-
tribute to dendrites and axons, similar to the subcellular dis-
tribution of liprin- in brain.
KIF1A Colocalizes with Liprin- and GRIP in Rat
Brain—We tested colocalization between KIF1A, liprin-, and
GRIP (a liprin--associated protein) by double or triple label
immunofluorescence staining on rat brain sections (Fig. 3). In
rat brain, the distribution of KIF1A overlapped that of both
liprin- (Fig. 3A, an example from the CA1 dendrites of hip-
pocampus) and GRIP (Fig. 3B, hippocampal CA1 dendrites).
Triple labeling of KIF1A, liprin-, or GRIP and NF-H (axons)
revealed that KIF1A colocalizes with liprin- (Fig. 3C) and
FIG. 2. KIF1A and liprin- distrib-
ute to both dendrites and axons in rat
brain and cultured hippocampal neu-
rons. A, specificity of KIF1A antibodies.
Equal amounts (100, 30, and 10 ng for
lanes 1–3 and 4–6) of GST fusion proteins
containing KIF1A (aa 657–937) and
KIF1B (aa 697–1223, equivalent region)
were immunoblotted with KIF1A (1131)
and GST antibodies. KIF1A antibodies
specifically recognize KIF1A but not the
closely related KIF1B. B, specificity of
liprin- (1120 and 1127) antibodies. HA-
liprin-1 and HA-liprin-2 expressed in
COS cells were immunoblotted with HA
and liprin (1120 and 1127) antibodies.
Liprin- antibodies equally recognize lip-
rin-1 and liprin-2. HA-liprin- proteins
with a ratio of 10:3:1 were loaded in lanes
1–3 and 4–6. C and D, characterization of
KIF1A (1131) and liprin- (1120 and
1127) antibodies. Subcellular fractions of
rat brain (S2 and P2 fractions) and ly-
sates of COS cells transfected with KIF1A
and liprin--1, respectively, were immu-
noblotted with the KIF1A and liprin- an-
tibodies indicated. P2, crude synapto-
somes; S2, supernatant after the removal
of the P2; Trans, transfected; Untrans,
untransfected. A small amount of endog-
enous liprin- proteins is detected in the
untransfected lanes. E–M, immunodistri-
bution of KIF1A and liprin- in vivo. Rat
brain slices, spinal cord sections, and cul-
tured hippocampal neurons (DIV 21) were
labeled by immunofluorescence staining
with combinations of KIF1A (1131), lip-
rin- (1127), MAP2, and neurofilament H
(NF-H) antibodies. KIF1A colocalizes
with MAP2, a dendritic marker, in cortex
(E, examples of colocalizations are indi-
cated by arrowheads) and hippocampus
(F). KIF1A colocalizes with NF-H, an ax-
onal marker, in the white matter of cere-
bellum (G) and axon bundles of spinal
cord (H). Preincubation of KIF1A antibod-
ies with immunogen eliminates the stain-
ing (K, hippocampal CA1 region). In cul-
tured hippocampal neurons, KIF1A
distributes to MAP2-positive dendrites
(M, arrowhead) as well as MAP2-negative
axons (M, arrow). Similar to KIF1A, lip-
rin- distributes to MAP2-positive den-
drites (I, hippocampal CA1) and NF-H-
positive axons (J, cerebellar white
matter). Preincubation of liprin- anti-
bodies with immunogen eliminates the
staining (L, hippocampal CA1). P, pyram-
idal cell layer; Sr, stratum radiatum. The
arrowheads indicate the sites of colocal-
ization. Size bar, 30 m (E–M).
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GRIP (Fig. 3D) in punctate subcellular structures in axons of
cerebellar white matter. These results indicate that KIF1A
colocalizes with liprin- and GRIP in vivo.
Ultrastructural Localization of KIF1A in Rat Brain by Im-
munoelectron Microscopy—To further characterize the distri-
bution of KIF1A in central neurons, we determined the subcel-
lular localization of KIF1A by immunogold EM analysis of
sections of rat neocortex (Fig. 4). KIF1A immunogold particles
were observed in various subcellular sites of the neurons in-
cluding microtubules (Fig. 4A), consistent with the function of
KIF1A as a kinesin motor moving along microtubule tracks.
KIF1A particles were observed at both pre- and postsynaptic
sites (Fig. 4B, example of an asymmetric spine synapse). Quan-
titative analysis revealed that KIF1A immunogold particles
were concentrated close to the pre- and postsynaptic mem-
branes (Fig. 4C, left panel). The density of KIF1A particles was
constant along the lateral plane of the synaptic membrane (Fig.
4C, right panel). Similar to KIF1A, liprin- is distributed in
pre- and postsynaptic sites of neurons at the EM level (21).
These results provide further evidence that KIF1A distributes
to dendritic and axonal sites.
KIF1A Coaccumulates with Liprin- in Ligated Sciatic
Nerves—Okada et al. (25) showed that KIF1A accumulates
with synaptophysin but not with syntaxin in ligated sciatic
nerve fibers, suggesting that KIF1A selectively transports syn-
aptophysin-containing vesicles. Since liprin- is detected in
sciatic nerve fibers by immunoblot analysis (data not shown),
we tested whether KIF1A comigrates with liprin- in axons of
motor neurons by the nerve ligation assay (Fig. 5). In rat sciatic
nerves ligated for 60 min, KIF1A and liprin- accumulated and
precisely colocalized on the proximal (cell body) side of the
ligation (Fig. 5A). Syntaxin also accumulated proximally but
did not colocalize with KIF1A (Fig. 5C), verifying the specificity
of KIF1A/liprin- coaccumulation. KIF1A, liprin-, and syn-
taxin did not accumulate on the distal side of the ligation (Fig.
5, B and D). These results suggest that KIF1A may antero-
gradely transport liprin- along axonal microtubules.
KIF1A Cofractionates and Forms a Complex with Liprin-
and Liprin--associated Proteins in Brain—If liprin- is a
KIF1A receptor linking KIF1A to its vesicular cargoes, KIF1A
and liprin- should cofractionate into the subcellular fractions
of neurons enriched with light membranes and synaptic vesi-
cles. To test this, we determined fractionation patterns of
KIF1A and liprin- in subcellular fractions of rat brain (Fig.
6A). Both KIF1A and liprin- were detected in the P3 (light
membranes) and LP2 (synaptic vesicles) fractions. In addition,
proteins associated with liprin- such as GRIP and GluR1 were
also detected in the P3 and LP2 fractions.
To further characterize the association of KIF1A and liprin-
with membranes, we performed the sucrose density flotation
assay (Fig. 6B). When samples enriched with membranes (see
“Experimental Procedures” for details) were loaded onto the
bottom of a discontinuous sucrose gradient, KIF1A and liprin-
floated and cofractionated into the light fractions (lanes 1–3),
along with GRIP, GluR2/3, and synaptotagmin, but not with
cortactin (Fig. 6B, left panel). Detergent treatment of the sam-
ples prior to centrifugation eliminated the floating (Fig. 6B,
right panel), suggesting that intact membranes are required for
flotation.
To determine whether KIF1A biochemically associates with
liprin- in the floated membranes, we performed coimmuno-
precipitation experiments on detergent extracts of the pooled
light membranes (fractions 1–3). KIF1A antibodies immuno-
precipitated KIF1A and coprecipitated liprin-, GRIP,
GluR2/3, and synaptotagmin, but not syntaxin and cortactin
(Fig. 6C). The liprin- (1120) antibody recognizes both liprin-1
and liprin-2 (Fig. 2B), and the GRIP (C8399) antibody recog-
nizes both GRIP1 and GRIP2/ABP (10, 11). Thus, further study
will be required to identify the specific isoforms of liprin- and
GRIP that bind to KIF1A in vivo. The coimmunoprecipitation
of GRIP and GluR2/3 is presumably due to their association
with liprin- (21). The coimmunoprecipitation of synaptotag-
min suggests that KIF1A is biochemically associated with syn-
aptotagmin and is similar to the reported association between
synaptotagmin and the closely related KIF1B (40). The lack of
coimmunoprecipitation of syntaxin that floated together with
KIF1A in the flotation assay (Fig. 6B) indicates the specific
association of KIF1A with its cargoes, and the lack of coimmu-
noprecipitation of cortactin with KIF1A is consistent with their
differential floating (Fig. 6B). Control immunoprecipitation
with guinea pig IgG did not bring down any of these proteins.
Interestingly, in an independent coimmunoprecipitation exper-
iment on detergent lysates of the floated samples, KIF1A an-
tibodies coimmunoprecipitated two additional liprin--binding
FIG. 3. KIF1A colocalizes with liprin- and GRIP in rat brain.
A and B, rat brain sections were doubly labeled by immunofluorescence
staining for KIF1A and liprin-a (A), or KIF1A and GRIP (B). The
distribution of KIF1A largely overlaps that of liprin- (A) and GRIP (B)
(examples from the CA1 dendrites of hippocampus). C and D, rat brain
sections were triply labeled for KIF1A (green), liprin- (red) or GRIP
(red), and NF-H (blue). KIF1A colocalizes with liprin- (C) or GRIP (D)
in punctate subcellular structures (arrowheads) of axons (examples
from axons of cerebellar white matter). Merge, green plus red. Size bar,
80 m (A–B) and 10 m (C–D).
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proteins, RIM (a scaffolding protein at active zones) and GIT1
(a multimodular scaffolding protein with an ADP-ribosylation
factor GTPase-activating protein activity) (Fig. 6D). In addi-
tion, KIF1A antibodies pulled down the PIX/Cool-1 (Fig. 6D),
a Rho-type guanine nucleotide exchange factor that directly
interacts with GIT1 (5, 6, 41).
In further coimmunoprecipitation experiments in a reverse
orientation, liprin- antibodies immunoprecipitated liprin-
and coprecipitated KIF1A and other liprin--associated pro-
teins including GRIP and RIM (Fig. 6E). In addition, GluR2/3
antibodies brought down GluR2/3 and coprecipitated GRIP,
liprin-, and KIF1A (Fig. 6F), strongly suggesting that KIF1A
and GluR2/3 are biochemically associated in the floated mem-
branes. Importantly, GluR2/3 antibodies did not bring down
RIM (Fig. 6F), suggesting that the KIF1A cargo vesicles con-
taining postsynaptic proteins may not contain presynaptic pro-
teins. Taken together, these results indicate that KIF1A
biochemically associates with liprin- and various liprin--
associated membrane, signaling, and scaffolding proteins in
the brain.
DISCUSSION
Cargo-binding Domain in KIF1A—We have shown that part
of the tail region of KIF1A, termed the LBD domain (aa 657–
1105), interacts with liprin- (Fig. 1). The closely related
KIF1B (1770 aa long) requires its tail region (aa 885–1770) for
association with vesicles containing synaptophysin, synapto-
tagmin, and SV2 (40). The C terminus of KIF1B, a shorter
splice variant of KIF1B, interacts with the PSD-95, SAP97, and
S-SCAM PDZ domain-containing proteins (42). KIF1C (1103 aa
long), the third member of the KIF1 family, uses its middle (aa
714–809) and C-terminal (last 60 aa residues) regions to in-
teract with protein-tyrosine phosphatase D1 and 14-3-3, re-
spectively (43, 44). Taken together, these results suggest that
members of the KIF1 family of kinesin motors use various
regions in their tails to associate with specific cargoes.
It has been reported that the C-terminal pleckstrin homology
domain of Unc104 plays an important role in the recognition of
phospholipids in cargo vesicle membranes (45, 46). Our results
demonstrate the LBD domain of KIF1A that is located in the
middle the molecule interacts with liprin-, a multimodular
protein that is linked to various proteins including membrane
proteins. Considering these results, it is conceivable that the
LBD and pleckstrin homology domains of KIF1A may associate
with cargo vesicles in a parallel fashion. In this model, the
pleckstrin homology domain of KIF1A may bind to the mem-
brane of a cargo vesicle, whereas liprin- may associate with
FIG. 4. Ultrastructural localization
of KIF1A by immunoelectron micros-
copy. Sections of rat cerebral cortex were
stained for KIF1A by immunogold EM.
Some of the KIF1A immunogold particles
associate with microtubules (A, arrows).
KIF1A distributes to both pre- and
postsynaptic sites (B, example from an
axospinous synapse). *, presynaptic nerve
terminal. Sp, postsynaptic spine. In a
quantitative analysis, KIF1A gold parti-
cles are concentrated at pre- and postsyn-
aptic membrane-proximal regions (C, left
panel; the right side from the midline cor-
responds to the postsynaptic region). The
distribution of gold particles remains con-
sistent along the lateral plane of the syn-
apse (C, right panel; 0 corresponds to the
center, and 1.0 corresponds to the edge of
the synapse). Size bar, 0.25 m.
FIG. 5. KIF1A and liprin- coaccumulate in ligated sciatic nerve fibers. Rat sciatic nerves were ligated for 60 min and labeled by double
immunofluorescence staining for KIF1A  liprin- (A and B), or KIF1A  syntaxin (C and D, negative control). KIF1A specifically coaccumulates
with liprin- (A) but not with syntaxin (C) in the proximal side of the ligation. The site of nerve ligation is indicated by two vertical arrows. Proximal
(cell body) (A and C) and distal (nerve terminal) (B and D) sides of the ligation site are indicated. Images on the proximal side of the ligation were
merged for better comparison. Size bar, 220 m.
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the proteins on the same cargo vesicle. This parallel binding
may help to determine the specificity or affinity of the associ-
ation of KIF1A with its cargoes.
KIF1A-mediated Transports in Dendrites and Axons—Previ-
ous studies on KIF1A were mainly focused on its transport in
the axonal compartment. However, several lines of evidence in
our study indicate that KIF1A exists in dendrites in addition to
axons: 1) localization of KIF1A in dendrites and axons of brain
and cultured neurons revealed by immunofluorescence stain-
ing (Fig. 2); 2) localization of KIF1A in both pre- and postsyn-
aptic sites revealed by immunogold EM analysis (Fig. 4); 3)
biochemical association of KIF1A with both axonal (synapto-
tagmin) and dendritic (AMPA receptors) proteins (Fig. 6). In
addition, movement of enhanced green fluorescent protein-
tagged KIF1A particles has been detected in proximal thick
neurites (probably dendrites) and axons of living cultured neu-
rons (30). This is consistent with the movement of enhanced
green fluorescent protein-tagged Unc104 particles observed in
both dendrites and axons of living C. elegans neurons (29).
Collectively, these results suggest that KIF1A/Unc104 proteins
are involved in the transport of neuronal proteins in both
dendrites and axons.
Liprin- as a KIF1A Receptor—Recent studies have begun to
uncover the motor-binding “receptors” in cargoes (47, 48),
which include coat proteins, scaffolding proteins, small
GTPases, transmembrane proteins, and other motor proteins.
Examples of motor receptors similar to our results are the
scaffolding proteins LIN-2LIN-7LIN-10 and JIP-1JIP-2JIP-3
proteins, which link KIF17 (49) and conventional kinesin (50),
respectively, to their specific cargoes. We propose that liprin-
functions as a cargo receptor for KIF1A, since liprin- directly
interacts with KIF1A and also associates with a variety of
membrane proteins such as LAR and AMPA receptors, thereby
potentially linking KIF1A to cargo vesicles.
It has been recently shown that Unc104 can exhibit a highly
processive movement through the formation of dimers at high
motor concentrations (34), which may occur in vivo through
clustering of motor proteins in phosphatidylinositol 4,5-
bisphosphate-containing rafts on the surface of cargo vesicles
(45, 46). Similar to Unc104, KIF1A also moves processively
along the microtubule in the single molecule motility assay, but
some KIF1A molecules occasionally exhibit slow movement
(34) that is similar to the previously reported biased diffusional
movement (32). This suggests that KIF1A may form a rela-
tively unstable dimer, perhaps due to the weakness of the
predicted neck coiled-coil probability, and raises the possibility
that KIF1A dimers may be stabilized by additional mecha-
nisms (34). Intriguingly, liprin- forms multimers (1), suggest-
FIG. 6. KIF1A cofractionates and forms a complex with liprin- and liprin--associated proteins in brain. A, KIF1A and liprin- are
detected in light membrane and synaptic vesicle fractions of brain. Subcellular fractions of adult rat brain were immunoblotted with the antibodies
indicated. KIF1A and liprin-, along with GRIP and AMPA receptors (GluR1), distribute to the light membrane (P3) and synaptic vesicle (LP2)
fractions. PSD-95 and synaptotagmin (a presynaptic vesicle protein) were visualized for comparison. H, rat brain homogenates; P1, nuclei and
other large debris; P2, crude synaptosomes; S2, supernatant after the removal of the P2; S3, cytosolic fraction; P3, light membranes; LP1, synaptic
membrane-enriched fraction; LS2, synaptic cytosol; LP2, synaptic vesicle-enriched fraction. B, cofractionation of KIF1A and liprin- in the sucrose
density flotation assay. Membrane-enriched samples from rat brain (see “Experimental Procedures” for more details) were loaded onto the bottom
of a discontinuous sucrose density gradient. KIF1A, along with liprin-, GRIP, and AMPA receptors (GluR2/3), but not cortactin, cofractionate in
light fractions (lanes 1–3, left panels). The floating was eliminated (right panel) by the addition of detergent to the samples before flotation (right
panels). C, coimmunoprecipitation of KIF1A with liprin-- and liprin--associated proteins in light membranes. Light membrane fractions (1–3)
from B were solubilized with detergent, immunoprecipitated with KIF1A (1131) antibodies or guinea pig IgG and immunoblotted with the
antibodies indicated. KIF1A coimmunoprecipitates with liprin-, GRIP, GluR2/3, and synaptotagmin but not syntaxin and cortactin. Input, 2%. D,
in an independent coimmunoprecipitation experiment similar to C, KIF1A selectively coimmunoprecipitates with RIM, GIT1, and PIX. Input, 1%.
E and F, detergent extracts of the floated light membranes were also immunoprecipitated with liprin- (1127), GluR2/3 (Chemicon) antibodies, or
rabbit IgG (negative control) and immunoblotted with the antibodies indicated. Both liprin- and GluR2/3 coimmunoprecipitate with KIF1A.
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ing the possibility that liprin- may contribute to the proces-
sive movement of KIF1A through the stabilization of KIF1A
dimers. This would suggest a dual role for liprin-, that of both
KIF1A receptor and a stabilizer of KIF1A dimers.
GRIP-associated Proteins as KIF1A Cargoes—GRIP and
GRIP-associated AMPA receptors comprise an important set of
potential KIF1A cargoes (Fig. 6, B–F). Several lines of evidence
indicate that GRIP is involved in neuronal transport. A signif-
icant amount of GRIP immuno-EM labeling associates with
vesicles that are often very close to microtubules (10, 14).
Biochemically, GRIP distributes to small membrane- and ves-
icle-enriched fractions (11, 14), similar to the subcellular dis-
tribution of liprin- (Fig. 6A). It was reported that synaptic
targeting of AMPA receptors is eliminated by disrupting the
liprin--GRIP interaction by various dominant negative con-
structs (21). A possible explanation for such results is that the
disruption may prevent the AMPA receptor-GRIP complex
from associating with KIF1A through liprin-. Taken together,
these results suggest that KIF1A, via liprin-, may transport
GRIP, AMPA receptors, and possibly other GRIP-associated
membrane and signaling proteins including ephrin ligands,
ephrin receptors, and GRASP-1 (15–18).
It has been reported that conventional kinesin heavy chain
interacts with GRIP1 and transports the AMPA receptor-GRIP
complex (51). This finding in conjunction with our results in-
dicates that the AMPA receptor-GRIP complex could be trans-
ported by more than one type of kinesin motor, KIF1A and
conventional kinesin. A similarly redundant transport mecha-
nism, which may exist for physiologically important cargoes,
has been identified for N-methyl-D-aspartate glutamate recep-
tors, which associate with KIF17 through the LIN-2LIN-
7LIN-10 complex (49) and with KIF1B through PSD-95 or
S-SCAM (42). Similarly, liprin- could also be transported by
both KIF1A and conventional kinesin. The minimal effects of
unc-104 mutations in C. elegans on the presynaptic targeting of
SYD-2 (19) may support this idea of a redundant mechanism
for liprin-/SYD-2 transport.
Intriguingly, GRIP1 steers conventional kinesin to dendrites
(51), which raises the question of whether KIF1A is also
steered to dendrites by association with liprin- or GRIP. Our
data indicate that postsynaptic GluR2/3 coimmunoprecipitates
with GRIP, liprin-, and KIF1A, but not with RIM, a presyn-
aptic active zone protein (Fig. 6F), suggesting that pre- and
postsynaptic cargo proteins partition into different KIF1A
cargo vesicles. This suggests that further work is needed to
identify the molecular determinants that direct the polarized
targeting of KIF1A cargo vesicles with pre- and postsynaptic
contents.
KIF1A, Liprin-, and Presynaptic Differentiation—Genetic
deletion of syd-2 in C. elegans and Dliprin- in Drosophila
leads to abnormal differentiation of the presynaptic active zone
(19, 20). One explanation for these results is that liprin-
functions as a structural component of the active zone (52). An
equally plausible hypothesis based on our results is that defec-
tive liprin- may limit KIF1A-mediated axonal transport of
various liprin--associated proteins involved in presynaptic de-
velopment. We demonstrated that KIF1A associates with lip-
rin- and liprin--associated proteins including RIM, GIT1,
and PIX (Fig. 6). RIM is a multimodular scaffolding protein of
the active zone that is involved in the regulation of neurotrans-
mitter release (8, 9). GIT1 distributes to both pre- and postsyn-
aptic sites at the EM level (2) and associates with Piccolo/
aczonin (53), a core component of active zones (54, 55).
Mutation in the dPix gene, a Drosophila homolog of mamma-
lian PIX, has been shown to modify synaptic structure and
targeting of various synaptic proteins (56). Taken together,
these results suggest that liprin- may mediate the transport
of these proteins to the nerve terminal for presynaptic
differentiation.
In conclusion, we have shown the first evidence for a protein
interaction of KIF1A with the multimodular protein liprin-.
Our results suggest that liprin-, as a KIF1A receptor, may
link KIF1A to various liprin--associated membrane, signal-
ing, and cytoskeletal proteins during their transport. It will be
of use in the near future to perform genetic analysis of the
identified protein interactions and determine the functional
association of liprin- with the dimerization and polarized tar-
geting of KIF1A.
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